On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Miltenyi Biotec (Germany)

InstitutionResearch output, impact & collaborations

Miltenyi Biotec (Germany) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Miltenyi Biotec (Germany)?

ScholarIQrecord summary

Miltenyi Biotec (Germany) is a research organisation in Cologne, DE. OpenAlex records 1,259 works and 159,222 citations for it. 835 researchers list it as their most recent affiliation.

How many works does Miltenyi Biotec (Germany) have?

ScholarIQindexed works

Miltenyi Biotec (Germany) has 1,259 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Miltenyi Biotec (Germany) have?

ScholarIQcitation count

Miltenyi Biotec (Germany) has 159,222 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Miltenyi Biotec (Germany)?

ScholarIQresearcher count

Miltenyi Biotec (Germany) has 835 researchers in the ScholarIQ index.

What is the average h-index at Miltenyi Biotec (Germany)?

ScholarIQavg h-index

Miltenyi Biotec (Germany) has an average h-index of 26 in OpenAlex.

What is the ROR of Miltenyi Biotec (Germany)?

ScholarIQror

The ROR for Miltenyi Biotec (Germany) is on the source record.

What is the OpenAlex record for Miltenyi Biotec (Germany)?

ScholarIQopenalex

The OpenAlex for Miltenyi Biotec (Germany) is on the source record.

What is the Wikidata of Miltenyi Biotec (Germany)?

ScholarIQwikidata

The Wikidata for Miltenyi Biotec (Germany) is on the source record.

Who are the most-cited researchers behind Miltenyi Biotec (Germany)?

ScholarIQtop researchers by citations
1
Jörg Mahlich · Health Systems, Economic Evaluations, Quality of Life
163 works1,837 citations

What are the most-cited papers on Miltenyi Biotec (Germany)?

ScholarIQmost cited works
Understanding the global measurement of willingness to pay in health
Jean A. McDougall, Wesley Furnback, Bruce C. M. Wang, Jörg Mahlich
Journal of Market Access & Health Policy. 2020163 CitationsOPEN ACCESS
Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
Jörg Mahlich, Rosarin Sruamsiri
Patient Preference and Adherence. 201651 CitationsOPEN ACCESS
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
Rosarin Sruamsiri, Kosuke Iwasaki, Wentao Tang, Jörg Mahlich
BMC Dermatology. 201850 CitationsOPEN ACCESS
Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study
Jörg Mahlich, Sunny Tsukazawa, Frank Wiegand
Drugs - Real World Outcomes. 201748 CitationsOPEN ACCESS
Cultural beliefs, utility values, and health technology assessment
Jörg Mahlich, Piyameth Dilokthornsakul, Rosarin Sruamsiri, Nathorn Chaiyakunapruk
Cost Effectiveness and Resource Allocation. 201845 CitationsOPEN ACCESS

How much of the research on Miltenyi Biotec (Germany) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
82%
Green
9%
Hybrid
0%
Bronze
9%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial